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OBJECTIVES Although different noninvasive tests have been proposed for detecting coronary artery disease
(CAD) in patients with hypertension and chest pain symptoms, the relative performance of
the available techniques has not been systematically assessed.
BACKGROUND Patients with hypertension frequently complain of chest pain and exhibit ischemic-like ST
segment changes on the exercise electrocardiogram (ECG). However, the specificity of such
changes for predicting significant CAD is very low, because these patients often exhibit a
normal coronary angiogram.
METHODS In 101 patients with hypertension, chest pain and positive exercise ECG, we performed
stress/rest myocardial single photon emission computed tomography with 99mTc-MIBI,
dipyridamole and dobutamine stress echocardiography and coronary angiography. All
patients had normal global ventricular function and 57 had left ventricular hypertrophy. All
were kept on ACE inhibitors during the study period.
RESULTS No patients had significant side effects during perfusion scintigraphy. Dose-limiting side
effects were observed in five patients with dipyridamole and in seven patients with
dobutamine. Only 56% of study patients exhibited significant CAD. Sensitivity, specificity,
accuracy, positive and negative predictive values were, respectively, 98%, 36%, 71%, 67% and
94% for perfusion scintigraphy, 61%, 91%, 74%, 90% and 64% for dipyridamole and 88%,
80%, 84%, 85% and 83% for dobutamine stress echocardiography.
CONCLUSIONS This study shows that stress echo in patients with hypertension yields a satisfactory diagnostic
accuracy for identifying significant epicardial CAD. Our results indicate that dobutamine
might be superior to dipyridamole. The low specificity of myocardial scintigraphy probably
relates to the fact that this method traces perfusion abnormalities, not necessarily caused by
epicardial CAD, possibly due to microvascular disease and not causing obvious wall motion
abnormalities. (J Am Coll Cardiol 1999;34:441–7) © 1999 by the American College of
Cardiology
In patients with arterial hypertension, the accurate diagnosis
of coronary artery disease (CAD) bears important therapeu-
tic and prognostic implications. Both diseases may result in
similar clinical events and frequently occur in the same
patient (1,2). Yet, the noninvasive detection of CAD in
hypertensive patients with chest pain remains an unresolved
issue (2). The use of exercise electrocardiography is limited
by the low specificity of the test, regardless of whether
hypertension is associated with left ventricular hypertrophy
or not (3). Moreover, although myocardial perfusion scin-
tigraphy has been proposed as a more specific alternative, its
specificity is far from being ideal (4–7). Recently, both
dipyridamole and dobutamine stress echocardiography have
been proposed as useful tools for the diagnosis of CAD in
hypertensive patients (8,9). However, comparative studies
using all the previously cited techniques have not been
performed. The aim of the present study was to assess the
relative diagnostic performance of rest/stress myocardial
perfusion scintigraphy, dipyridamole and dobutamine stress
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echocardiography for the detection of CAD in hypertensive
patients with chest pain and exercise-induced diagnostic ST
segment depression.
PATIENTS AND METHODS
Study population. We studied 101 consecutive patients
(55 men, aged 61 6 10 years, range 45 to 76) with arterial
hypertension (duration from diagnosis 22 6 20 months,
range 2 to 120) referred to our cardiology outpatient clinic
for rest or effort typical angina and a positive exercise test.
None of the patients had had a previous myocardial infarc-
tion. To avoid interference with the study investigations, all
antiischemic drugs, such as nitrates, beta-adrenergic block-
ing agents and calcium antagonists, were discontinued for
the entire study duration. To control blood pressure during
the study period, patients were given ACE inhibitors or
diuretics as necessary. All study subjects had a reproducibly
positive exercise test and were submitted to the following
investigations, which were performed in the order in which
they are presented. Each patient gave his or her written
informed consent.
Stress-rest myocardial perfusion imaging. Treadmill ex-
ercise was performed following the modified Bruce proto-
col; the 12-lead electrocardiogram (ECG) and the blood
pressure (cuff sphygmomanometer) were recorded at rest
and every minute during exercise and recovery. The follow-
ing criteria were used for discontinuing the test: 1) achieve-
ment of the maximal predicted heart rate; 2) occurrence of
$2.0 mm rectilinear or downsloping ST-segment depres-
sion on at least one precordial or two peripheral leads, with
or without angina; 3) severe dyspnea or fatigue; 4) repetitive
ventricular arrhythmias; and 5) a greater than 10-mm Hg
decrease in systolic blood pressure at any exercise step. For
all tests, total exercise time and rate-pressure product (RPP)
at peak exercise were analyzed. A test was considered
positive in the presence of $1.0 mm rectilinear or
downsloping ST-segment depression, calculated from base-
line levels, on at least one precordial or two peripheral leads,
with or without angina.
Myocardial perfusion imaging was performed with 99m-
Tc-MIBI. The tracer (925 Mbq) was given intravenously
peak exercise and 48 h postexercise, at rest. Single photon
emission computed tomography (SPECT) acquisitions
were performed 90 min after tracer injection, with a large
field of view, single-head rotating gamma camera (Starcam
400 AC; General Electric, Milwaukee, Wisconsin). Sixty-
four angular projections (64 3 64 matrix) were obtained in
approximately 40 min over 360°. Transaxial slices, 6.2 cm
thick, were reconstructed using a filtered back projection
algorythm with a Butterworth filter (cutoff frequency 5 0.4
cycles/pixel). No correction for attenuation was performed.
Interpretation of scintigraphic images. From the raw
scintigraphic data, horizontal long-axis, vertical long-axis
and short-axis tomograms were reconstructed and reported
independently by two experienced observers, unaware of
each patient’s identity and angiographic findings. The left
ventricular myocardium was divided into six segments:
anterior, apical, septal, inferior, posterior and lateral. Images
were displayed in random order and graded using a four-
point score (0 5 normal, 1 5 moderate uptake reduction,
2 5 severe uptake reduction, 3 5 absent uptake). A test was
considered positive when there was $1 point score change
between rest and stress images in at least two adjacent
tomographic slices. In case of disagreement, a majority
decision was taken by including a third observer.
Stress echocardiography. Dobutamine and dipyridamole
stress echocardiography were performed on separate days in
random order. Dobutamine was infused intravenously (i.v.)
with a mechanical pump, starting with a dose of 5 mg/kg/
min and increasing the rate at 3-min intervals to 10, 20, 30
and 40 mg/kg/min. During the infusion, the 12-lead ECG
was monitored continuously and recorded on paper every
2 min. Blood pressure was measured by sphygmomanome-
ter at 3-min intervals. Test end points were: 1) achievement
of peak dobutamine dose; 2) attainment of 85% of the
maximal predicted heart rate; 3) development of severe
angina or ST-segment depression $2 mm; 4) appearance
of a new abnormality in systolic wall motion or wall
thickening; and 5) occurrence of severe side effects. The
latter included hypertension (systolic pressure .220 mm
Hg, diastolic pressure .120 mm Hg), hypotension
(.30 mm Hg fall of systolic pressure), dyspnea, significant
ventricular or supraventricular arrhythmia ($6 beats su-
praventricular tachycardia or $3 beats ventricular tachycar-
dia) and nausea/vomiting.
Dipyridamole was infused at 0.56 mg/kg over 4 min. In
the event of a negative test, a further 0.28-mg/kg dose was
given in 2 min. The maximal cumulative dose was therefore
0.84 mg/kg. Aminophylline (up to 240 mg i.v. over 3 min),
was readily at hand. The 12-lead ECG and blood pressure
were recorded at 1-min intervals during the whole investi-
gation.
All study subjects had adequate transthoracic acoustic
windows. Studies were performed with an ultrasound sys-
tem (Sonos 2500; Hewlett-Packard, Andover, Massachu-
setts) equipped with a 2.5/2.0-MHz transducer and were
recorded on half-inch VHS tape. Images were also digitized
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at each stage from four views, using a commercially available
stress program (Sonos 2500 ultrasound system; Hewlett-
Packard). R-Wave triggering was used to capture a repre-
sentative cardiac cycle in each view at 30 frames per second.
The first 400 ms of the selected cycle were displayed in a
continuous-loop format to evaluate systolic wall thickening
without the potential confounding influence of diastolic
septal motion. The generated cineloops were recorded on
VHS tape and stored on a rewritable optical disk (Hewlett-
Packard) for later review.
Each subject was examined in the left lateral decubitus.
Standard M-mode measurements were obtained at the
papillary muscle level. Left ventricular mass was calculated
by Devereux and Reichek’s formula and normalized for
body surface (left ventricular mass index [LVMI] in g/m2)
(10). The LVMI obtained in study patients was compared
with the value obtained from an age- and gender-matched
control group in our echocardiography data base.
Echocardiographic image processing and analysis. Two-
dimensional echocardiograms were recorded continuosly
during both dobutamine and dipyridamole administration.
In the baseline studies, as well as during stress, all standard
echocardiographic views were obtained whenever possible.
Both analog and digital images were interpreted by two
independent investigators who had no knowledge of pa-
tients’ status. The left ventricle was divided into 16 seg-
ments as previously described (11). For each segment,
systolic wall motion and thickening were visually graded
with the following semiquantitative scoring system: 1 5
normal or hyperkinesia; 2 5 hypokinesia; 3 5 akinesia; and
4 5 dyskinesia. Inadequately visualized segments were not
scored. A test result was considered positive when the wall
motion score increased by one grade or more at peak stress.
In positive dobutamine tests, the dobutamine infusion time
(minutes) was also determined as the time interval from the
beginning of drug infusion to the occurrence of stress-
induced asynergy.
To compare SPECT and echocardiographic images, the
left ventricle was also divided into six major segments:
anterior, apical, septal, inferior, posterior and lateral.
Coronary angiography. All patients underwent coronary
angiography and left ventriculography by the Judkins tech-
nique. Ventriculography was performed in the 30° right
anterior oblique and 60° left anterior oblique views. Coro-
nary arteries were selectively injected in multiple views and,
to avoid overestimation of coronary stenosis due to vaso-
constriction, left and right coronary injections were also
performed after intracoronary administration of nitroglyc-
erine (100 mg, as a bolus). End-diastolic cine frames were
selected for optimal stenosis visualization and magnified
53. Eccentric stenoses were evaluated in two orthogonal
views. A normal arterial segment was identified immediately
proximally and distally to the lesion and measured with an
electronic caliper. The minimal stenosis diameter was also
measured and severity was expressed as percent reduction of
normal diameter. Significant CAD was considered .50%
reduction in luminal diameter of at least one major epicar-
dial vessel.
Statistical analysis. When not in absolute numbers, data
are reported as mean 6 1 standard deviation. Statistical
significance was evaluated by the Student t test or a
chi-square test when indicated. A p value ,0.05 was
considered significant. Bonferroni’s correction for multiple
testing was performed where appropriate.
RESULTS
Clinical data. Of the 101 patients studied, 57 (56%) had
significant coronary disease, and the remaining 44 (44%)
exhibited either angiographically smooth coronary arteries
(34 patients) or minor vessel wall irregularities (10 patients).
Twenty patients had one-vessel, 26 had two-vessel and the
remaining 11 had three-vessel disease. Duration of hyper-
tension from diagnosis was 23 6 22 months in CAD
patients and 21 6 18 months in patients with normal
coronary arteries (p 5 NS).
Of the 57 patients with CAD, 14 exhibited a normal
resting electrocardiogram, 5 had left ventricular hypertro-
phy, 1 had left anterior hemiblock and 39 had different
degrees of ST abnormalities. Of the patients with normal
coronary arteries, 17 had a normal resting electrocardio-
gram, 2 had had left ventricular hypertrophy, 7 had left
anterior hemiblock and 20 had various degrees of ST-T
abnormalities. Although left ventricular hypertrophy was
not a frequent finding on the surface ECG, mean left
ventricular mass index (LVMI) was greater than in a
matched group of normal controls (116 6 42 vs. 90 6
17 g/m2, p , 0.05).
When analyzed separately, patients with CAD showed a
Table 1. Exercise Parameters Recorded on Study Patients
Pred.
HR
RPP
1 mm
RPP
max
Time
1 mm
Time
max Recovery
ST
max Leads Angina
NCA 87 6 16 23,216 6 6637 26,495 6 4893 509 6 143 647 6 175 238 6 125 1.6 6 0.6 3.0 6 0.8 25
CAD 83 6 11 21,612 6 4869* 24,885 6 4990 434 6 203 562 6 193* 345 6 182* 1.7 6 0.7 2.8 6 0.9 27
Angina 5 patients reporting chest pain on exercise testing; CAD 5 coronary artery disease; Leads 5 number of leads showing diagnostic ST segment depression; NCA 5 normal
coronary arteries; pred HR 5 percent of maximal predicted heart rate; Recovery 5 time for ECG recovery (s); RPP 1 mm and RPP max 5 rate-pressure product at 1-mm ST
segment depression and at peak exercise (mm Hg 3 beats/min); ST max 5 maximal ST segment depression (mm); Time 1 mm and Time max 5 time to 1-mm ST segment
depression and total exercise duration (s).
*p , 0.05.
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greater LVMI than those with normal coronary arteries
(130 6 48 vs. 101 6 24 g/m2, p , 0.05). In the latter,
LVMI was not significantly different from the control
group.
The mean blood pressure values obtained just before
performing the three tests, were 151 6 19/88 6 9 mm Hg
in patients with CAD, and 151 6 19/89 6 9 mm Hg in
patients with normal coronary arteries (p 5 NS). At peak
exercise (at the time of perfusion scintigraphy), these values
increased to 192 6 21/96 6 12 and 189 6 23/99 6
12 mm Hg, respectively (p 5 NS).
Exercise performance was significantly better in patients
with normal coronary arteries, as evidenced by higher RPPs
at 1-mm ST segment depression and peak exercise, longer
exercise duration and shorter recovery time (Table 1).
Noninvasive detection of coronary artery disease. Dipyr-
idamole and dobutamine stress echocardiograms and perfu-
sion scintigrams identified, respectively, 35, 50 and 56 of the
57 patients with CAD, with a relative sensitivity of 61%,
88% and 98%. The three tests correctly identified, respec-
tively, 40, 35 and 16 of the 44 patients with normal coronary
arteries, yielding a specificity of 91%, 80% and 36%.
The negative predictive value was highest (94%) for
methoxy-isobutyl-isonitrile (MIBI), while the positive pre-
dictive value was greatest for dypiridamole (90%). Dobut-
amine had similar positive and negative predictive value
(85% to 83%). As a result, overall diagnostic accuracy for
dipyridamole-dobutamine and perfusion scintigraphy was
74%, 84% and 71%, respectively. The results of the tests
were concordant in 46 patients (32 with CAD and 12 with
normal coronary arteries). The relative performance of the
three tests are shown in Table 2 and Figure 1. The
sensitivity to predict the presence of single, double and triple
vessel disease was 31%, 69% and 82% for dipyridamole,
85%, 88% and 91% for dobutamine and 95%, 100% and
100% for MIBI, respectively. Dobutamine infusion time
was 13.2 6 3.7, 13.6 6 3.1 and 12.9 6 2.9 mg/kg in one-,
two- and three-vessel disease, respectively (p 5 NS). The
sensitivity of the three tests to detect isolated left anterior
descending coronary disease (five patients, mean percent
stenosis 71 6 21%) was 40%, 80% and 100%, respectively.
These figures were 78%, 93% and 96%, respectively, when
left anterior descending coronary disease was present in
patients with multivessel disease (Tables 3 and 4).
Concordance of tests. Ten patients with normal coronary
arteries and 25 with CAD had resting wall motion abnor-
malities in 21 and 87 segments, respectively. Eight (38%)
and 44 (51%) of these dysfunctioning segments also showed
resting underperfusion on the resting MIBI scan in five
patients with normal coronary arteries and in 22 patients
with CAD. Stress-induced MIBI perfusion defects and
dobutamine-induced wall motion abnormalities were ob-
served in the same segments in six patients with normal
coronary arteries (seven segments) and in 40 patients with
CAD (70 segments). Dipyridamole-induced wall motion
abnormalities and stress-MIBI perfusion defects were ob-
served in the same segments in two patients with normal
coronary arteries (three segments) and in 28 patients with
CAD (44 segments). Finally, all three tests were positive
and concordant in two patients with normal coronary
arteries (three segments) and in 25 patients with CAD (37
segments). All tests were negative in four patients with
normal coronary arteries and in none of CAD patients.
Overall, they gave concordant results in 31 patients (31%).
Figure 1. Histogram showing sensitivity (SENS), specificity
(SPEC), accuracy (ACC), negative (NPV) and positive (PPV)
predictive value of dipyridamole (Dip), dobutamine (DOB) stress
echocardiography, and myocardial perfusion scintigraphy (MIBI),
for the detection of CAD, in hypertensive patients with chest pain
and positive exercise test. Open bars: MIBI; solid bars: Dip;
striped bars: DOB.
Table 2. Relative Performance of the Three Tests for the Diagnosis of CAD
Dip Dob MIBI
p Values
Dip vs.
Dob
Dip vs.
MIBI
Dob vs.
MIBI
Sensitivity 61 88 98 0.006 , 0.0006 0.12
Specificity 91 80 36 0.78 , 0.0006 , 0.0006
Accuracy 74 84 71 0.48 1.26 0.12
Negative predictive value 64 83 94 0.18 0.06 1.62
Positive predictive value 90 85 67 2.82 0.036 0.06
Dip 5 dipyridamole; Dob 5 dobutamine; MIBI 5 myocardial perfusion scintigraphy.
Differences were regarded as significant when p , 0.05, after Bonferroni’s correction for multiple testing.
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Side effects and ECG responses during stress-echo. Of
the 101 patients studied, 5 (5%) had significant side effects
with dipyridamole and 7 (7%) with dobutamine. The
maximal dipyridamole dose could be administered in 48
patients with coronary disease (84%) and in 39 patients with
normal coronary arteries (89%); in the two groups, mean
administered dobutamine dose was 28 6 8 mg and 31 6
8 mg (p 5 NS), respectively.
The percent of maximal predicted heart rate achieved
during dobutamine was 77 6 10 and 74 6 11% (p 5 NS)
in patients with normal coronary arteries and CAD, respec-
tively. With exercise (at the time of perfusion scintigraphy),
the percent of the predicted heart rate achieved was 87 6
16% and 83 6 11%, respectively (p , 0.0001 for both
groups, exercise vs. dobutamine). Four of the seven patients
with coronary disease who had a negative dobutamine test
achieved .85% of maximal predicted heart rate; the re-
maining three patients could not terminate the protocol
because of repetitive ventricular ectopic beats.
The presence of angina and ST-segment depression
during stress echocardiography were significantly more fre-
quent in patients with coronary disease than in patients with
normal coronary arteries. Accordingly, angina and ST-
segment depression were more likely to appear during a
positive stress echocardiogram (Table 5).
DISCUSSION
In hypertensive patients, the distinction between anginal
symptoms caused by CAD and those caused by hyperten-
sion is important, because treatment goals and management
may be different. If the presence of epicardial CAD can be
excluded by noninvasive means, the risks and expense of
coronary arteriography can be avoided. However, the use of
exercise stress testing for determining the probability of
obstructive epicardial CAD in hypertensive patients lacks
specificity (2,3). Undiagnosed hypertrophy may be present
even in the absence of ECG signs (12), and exercise-
induced diagnostic ST-segment depression may result from
transmural flow redistribution due to increased left ventric-
ular mass rather than to obstructive epicardial CAD (13).
This is why a number of noninvasive investigations have
been proposed, in an attempt to overcome the limitations of
exercise testing.
Comparison of noninvasive tests. The results of our study
confirm the poor diagnostic accuracy of the exercise ECG,
because 44 patients with a positive test had angiographically
normal coronary arteries. Both dipyridamole and dobut-
amine stress echocardiography yielded a superior diagnostic
accuracy. Specifically, and in keeping with previous investi-
gations (14,15), dipyridamole exhibited very high specificity
with a relatively low sensitivity for the detection of CAD.
Conversely, dobutamine yielded high sensitivity (88%) with
satisfactory specificity (80%).
The discrepancy between the results obtained by the two
stressors probably relates to the mechanisms by which they
cause ischemia. Dipyridamole induces transmural flow re-
distribution via inhibition of adenosine breakdown, which
causes arteriolar vasodilation and subendocardial “steal.”
Therefore, this agent causes ischemia almost exclusively by
altering coronary hemodynamics in the presence of critical
epicardial disease. Indeed, in our study, the sensitivity of the
test progressively increased with the progression of coronary
disease extent. This suggests that the greater the impair-
ment of coronary hemodynamics, the more likely dipyrida-
mole is to cause ischemia. Dobutamine increases myocardial
oxygen consumption by sympathetic stimulation that causes
heart rate and contractility to increase (16–18). Like dipyr-
idamole, this agent causes arteriolar coronary dilation (and
transmural flow redistribution), due to metabolic stimula-
tion and increased ATP breakdown; in addition, it causes
Table 3. Sensitivity of Dipyridamole, Dobutamine Stress
Echocardiography and Myocardial Perfusion Scintigraphy for
the Detection of Single-, Double- and Triple-Vessel Disease
CAD Dipyridamole Dobutamine
Myocardial
Perfusion
Scintigraphy
Single vessel
(20 pts)
31% 85% 95%
Double vessel
(26 pts)
69% 88% 100%
Triple vessel
(11 pts)
82% 91% 100%
Table 4. Sensitivity of Dipyridamole, Dobutamine Stress Echo
and Myocardial Perfusion Scintigraphy for the Detection of
Isolated Left Anterior Descending Coronary Artery Disease
With and Without Multivessel Disease
LAD LAD 1 MVD
Dipyridamole (2/5) 40% (21/27) 78%
Dobutamine (4/5) 80% (25/27) 93%
Myocardial perfusion
scintigraphy
(5/5) 100% (26/27) 96%
LAD 5 left anterior descending coronary artery disease; LAD 1 MVD 5 LAD and
multivessel disease.
Table 5. Patients Developing Angina, Diagnostic ST-segment
Depression or Both, During Dipyridamole and Dobutamine
Stress Echocardiography
CAD NCA
Angina during Dip 25 (181) 16 (31)
ST during Dip 24 (201) 11 (21)
Both 17 (141) 7 (21)
Angina during Dob 18 (161) 11 (41)
ST during Dob 28 (261) 10 (41)
Both 12 (111) 5 (31)
Dip 5 dipyridamole; Dob 5 dobutamine; NCA 5 normal coronary arteries.
Numbers between brackets refer to patients developing wall motion abnormalities
during each test.
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oxygen demand to increase. Therefore, it is not surprising
that this agent yields a greater sensitivity for detecting
epicardial coronary disease, with very little loss in specificity
and greater diagnostic accuracy. Furthermore, the ability of
dobutamine stress echocardiography to detect epicardial
coronary stenoses was not apparently related to the extent of
the disease. In fact, the sensitivity of the test did not
significantly increase with the progression of disease sever-
ity, as also evidenced by similar dobutamine infusion times
in patients with one-, two- or three-vessel disease. This
finding is at variance with previous reports, which showed a
direct relation between dobutamine sensitivity and the
extent of CAD (18). It is possible that in our selected
population of hypertensive patients, the likelihood of a
positive test may have somewhat increased due to a reduc-
tion of the ischemic threshold induced by greater LVMI or
coexisting microvascular abnormalities, regardless the extent
of CAD.
Therefore, when patients with hypertension, chest pain
and a positive exercise test are elected to undergo further
diagnostic stratification with stress echocardiography, do-
butamine rather than dipyridamole should be considered as
the first-choice pharmacologic stressor. Although the addi-
tion of atropine at peak pharmacologic stimulation has been
shown to improve the diagnostic accuracy of both dipyrid-
amole and dobutamine stress echocardiography, the diag-
nostic accuracy of dobutamine remains higher (19,20).
Exercise may represent a valid alternative to pharmacologic
stressors, possibly yielding even better diagnostic accuracy
than dobutamine when performed by expert echocardio-
graphers (15).
Significance of perfusion abnormalities. The diagnostic
value of dobutamine stress echo also appears to be better
than that of MIBI perfusion scintigraphy. Indeed, and in
agreement with previous studies (4–7), stress-rest myocar-
dial perfusion scintigraphy frequently yielded false-positive
results, possibly due to microvascular abnormalities (21,22).
Indeed, microvascular dysfunction, which has been previ-
ously hypothesized as the cause of ST-segment abnormali-
ties during dipyridamole administration in patients with
arterial hypertension and chest pain (8), may be the cause of
inhomogeneous myocardial perfusion both at rest and dur-
ing stress. Increased medial thickness has been reported in
coronary arterioles from hypertensive patients undergoing
endomyocardial biopsy (23). This could explain the reduc-
tion in coronary reserve and maximal flow capacity consis-
tently observed in these patients, whose flow response to
atrial pacing is blunted and is further decreased by the
administration of ergonovine (24). Thus, besides structural
alterations, the microvasculature may also show functional
derangements leading to abnormal vasoconstriction in re-
sponse to vasoactive stimuli. The reduction in coronary flow
reserve is unrelated to the presence of left ventricular
hypertrophy (25). Accordingly, we found no relation be-
tween left ventricular mass and exercise-induced perfusion
defects, which further supports the hypothesis that a micro-
vascular disorder is present in the coronary circulation of
patients with hypertension.
The simple scrutiny of these figures should be enough to
allow the conclusion that in patients with hypertension,
angina and a positive exercise test, stress-rest myocardial
perfusion scintigraphy does not allow an accurate prediction
of obstructive epicardial coronary disease. When noninva-
sive assessment is envisaged, stress echocardiography should
be preferred.
Conclusions. Chest pain is a common complaint among
hypertensive patients. Hypertension and coronary disease
may present with symptoms and signs that are clinically
indistinguishable. A positive exercise ECG is not reliably
predictive of obstructive epicardial CAD, and should
prompt the physician to pursue additional noninvasive
testing. For this purpose, stress echocardiography appears to
be the most valuable tool. Among pharmacologic stressors,
dobutamine stress echocardiography should be the first
choice. Myocardial perfusion imaging yields a very low
specificity, and therefore does not help in excluding the
presence of epicardial coronary disease in hypertensive
patients with chest pain and a positive exercise test. How-
ever, carefully performed prospective studies on the prog-
nostic significance of perfusion defects in hypertensive
patients with chest pain and positive exercise test are not
available. Long-term follow up of such patients would merit
major consideration.
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